Roche Holding AG (JOBS) Says Diabetes Drug Better Than Merck & Co., Inc.'s (JOBS) Januvia

Bookmark and Share

Dow Jones -- Roche Holding AG said Wednesday an experimental once-weekly treatment under development works better in treating a type of diabetes than Merck & Co. Inc.'s (MRK) Januvia, according to a clinical study.
MORE ON THIS TOPIC